Yoshizato R, Miura M, Shitaoka K, Matsuoka Y, Higashiura A, Yamamoto A
Heliyon. 2024; 10(23):e40837.
PMID: 39698082
PMC: 11652855.
DOI: 10.1016/j.heliyon.2024.e40837.
Wu X, Fang S
Front Immunol. 2024; 15:1494887.
PMID: 39588373
PMC: 11586384.
DOI: 10.3389/fimmu.2024.1494887.
Little J, Rauseo A, Zuniga-Moya J, Spec A, Pappas P, Perfect J
Open Forum Infect Dis. 2024; 11(7):ofae363.
PMID: 39045011
PMC: 11263878.
DOI: 10.1093/ofid/ofae363.
Mayer B, Zhang L, deCamp A, Yu C, Sato A, Angier H
Pharmaceutics. 2024; 16(5).
PMID: 38794258
PMC: 11125931.
DOI: 10.3390/pharmaceutics16050594.
Iyer K, Yan Z, Ross S
Front Microbiol. 2024; 15:1382953.
PMID: 38650890
PMC: 11033450.
DOI: 10.3389/fmicb.2024.1382953.
Identification of Hit Compounds Using Artificial Intelligence for the Management of Allergic Diseases.
Byun J, Tai J, Kim B, Kim J, Jung S, Lee J
Int J Mol Sci. 2024; 25(4).
PMID: 38396957
PMC: 10889320.
DOI: 10.3390/ijms25042280.
Identification of potential therapeutic drugs targeting core genes for systemic lupus erythematosus (SLE) and coexisting COVID-19: Insights from bioinformatic analyses.
Chen C, Zhang H, Lin Y, Lu M, Liao Q, Zhang S
Immun Inflamm Dis. 2023; 11(11):e1087.
PMID: 38018597
PMC: 10659756.
DOI: 10.1002/iid3.1087.
Thermoresponsive Polypeptide Fused L-Asparaginase with Mitigated Immunogenicity and Enhanced Efficacy in Treating Hematologic Malignancies.
Zhang S, Sun Y, Zhang L, Zhang F, Gao W
Adv Sci (Weinh). 2023; 10(23):e2300469.
PMID: 37271878
PMC: 10427413.
DOI: 10.1002/advs.202300469.
The development of COVID-19 treatment.
Yuan Y, Jiao B, Qu L, Yang D, Liu R
Front Immunol. 2023; 14:1125246.
PMID: 36776881
PMC: 9909293.
DOI: 10.3389/fimmu.2023.1125246.
Immune Checkpoint Glycoproteins Have Polymorphism: Are Monoclonal Antibodies Too Specific?.
Jalalizadeh M, Yadollahvandmiandoab R, Reis L
Curr Oncol. 2023; 30(1):1267-1274.
PMID: 36661747
PMC: 9857673.
DOI: 10.3390/curroncol30010098.
Patient-Derived Antibody Data Yields Development of Broadly Cross-Protective Monoclonal Antibody against ST258 Carbapenem-Resistant .
Banerjee K, Motley M, Boniche-Alfaro C, Bhattacharya S, Shah R, Ardizzone A
Microbiol Spectr. 2022; 10(4):e0176022.
PMID: 35862974
PMC: 9430753.
DOI: 10.1128/spectrum.01760-22.
Immune response in COVID-19: what is next?.
Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L
Cell Death Differ. 2022; 29(6):1107-1122.
PMID: 35581387
PMC: 9110941.
DOI: 10.1038/s41418-022-01015-x.
Targeted delivery of a PROTAC induced PDEδ degrader by a biomimetic drug delivery system for enhanced cytotoxicity against pancreatic cancer cells.
Fan R, He S, Wang Y, Qiao J, Liu H, Galstyan L
Am J Cancer Res. 2022; 12(3):1027-1041.
PMID: 35411249
PMC: 8984894.
Biotechnology Applications of Cell-Free Expression Systems.
Brookwell A, Oza J, Caschera F
Life (Basel). 2021; 11(12).
PMID: 34947898
PMC: 8705439.
DOI: 10.3390/life11121367.
Toward High-Throughput Cryogenic IR Fingerprinting of Mobility-Separated Glycan Isomers.
Warnke S, Ben Faleh A, Rizzo T
ACS Meas Sci Au. 2021; 1(3):157-164.
PMID: 34939078
PMC: 8679095.
DOI: 10.1021/acsmeasuresciau.1c00018.
Therapeutic and Systemic Adverse Events of Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 axis for Clinical Management of NSCLC.
Chen J, Alduais Y, Chen B
Cell Transplant. 2021; 30:9636897211041587.
PMID: 34606729
PMC: 8493325.
DOI: 10.1177/09636897211041587.
Autoimmune diseases - New insights into a troublesome field.
Lung T, Sakem B, Hemmerle A, Nydegger M, Risch M, Risch L
J Transl Autoimmun. 2021; 4:100108.
PMID: 34179743
PMC: 8188057.
DOI: 10.1016/j.jtauto.2021.100108.
Early Days of Tenascin-R Research: Two Approaches Discovered and Shed Light on Tenascin-R.
Rathjen F, Hodge R
Front Immunol. 2021; 11:612482.
PMID: 33488619
PMC: 7820773.
DOI: 10.3389/fimmu.2020.612482.
Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview.
Ali M, Zhang Z, Gao Q, Pan M, Rowan E, Zhang J
Immunol Res. 2020; 68(6):325-339.
PMID: 33161557
PMC: 7648849.
DOI: 10.1007/s12026-020-09159-z.
Past, Present, and Future of Anticancer Nanomedicine.
Kim K, Khang D
Int J Nanomedicine. 2020; 15:5719-5743.
PMID: 32821098
PMC: 7418170.
DOI: 10.2147/IJN.S254774.